Company: TGE
Filing Date: 2025-11-21
Form Type: POS AM
Source: 0001213900-25-113604
Chunk: 5

Company: Generation Essentials Group
Filing Date: 2025-11-21
Form: POS AM
Chunk 5
---
 underwritten offerings, directly to market makers of our securities or through any other means described in the section
entitled “Plan of Distribution” herein. In connection with any sales of securities offered hereunder, the Selling Securityholders,
any underwriters, agents, brokers or dealers participating in such sales may be deemed to be “underwriters” within the meaning
of the Securities Act of 1933, as amended, or the “Securities Act.”

The Class A Ordinary
Shares are listed on the New York Stock Exchange (“NYSE”) under the trading symbol “TGE” and the Warrants are
listed on the New York Stock Exchange American (“NYSE American”) under the trading symbol “TGE WS.” On November
19, 2025, the closing price for the Class A Ordinary Shares on NYSE was US1.20. On November 19, 2025, the closing price for the
Warrants on NYSE American was US$0.1896.

The securities registered
herein are identified in this prospectus as the “Registered Securities.” In connection with the Business Combination, holders
of 13,120,874 BSII Public Shares exercised their right to redeem their shares for cash at a redemption price of approximately US$10.30
per share, for an aggregate redemption amount of approximately US$135.2 million, representing approximately 85.8% of the total BSII Class
A Shares outstanding as of the record date of May 5, 2025 (the “Record Date”). Subject to the AMTD Lock-up Obligations, the
Selling Securityholders can sell, under this prospectus, up to (i) 57,401,944 Class A Ordinary Shares constituting approximately 88.7%
of the total issued and outstanding Ordinary Shares (assuming exercise of all outstanding Warrants), and (ii) 11,120,000 Warrants, representing
approximately 68.6% of our outstanding Warrants, as of the date of this prospectus. Sales of a substantial number of Registered Securities,
or the perception that those sales might occur, could result in a significant decline in the public trading price of our securities and
could impair our ability to raise capital through the sale or issuance of additional equity securities. We are unable to predict the
effect that such sales may have on the prevailing market price of our securities. Despite such a decline in the public trading price,
certain Selling Securityholders may still experience a positive rate of return on the Registered Securities